Sivan et al. investigated melanoma growth in mice [62] and showed that oral administration of Bifidobacterium improved tumour control to the same degree as PD-L1-specific antibody therapy, and that combination therapy nearly eradicated tumour outgrowth [94]. This evidence concerns the gene CD274 and neoplasm.